Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma
Approximately 25% to 40% of patients with chronic obstructive pulmonary disease (COPD) have the eosinophilic endotype. It is important to identify this group accurately because they are more symptomatic and are at increased risk for exacerbations and accelerated decline in forced expiratory volume i...
Enregistré dans:
Auteurs principaux: | Andrew Li, Hiang Ping Chan, Phyllis X.L. Gan, Mei Fong Liew, W.S. Fred Wong, Hui-Fang Lim |
---|---|
Format: | article |
Langue: | EN |
Publié: |
The Korean Association of Internal Medicine
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/73dee75f007948f68c61dda89afb3cae |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
par: Choi JH, et autres
Publié: (2021) -
Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET
par: Kahnert K, et autres
Publié: (2021) -
Considerations for managing chronic obstructive pulmonary disease in the elderly
par: Taffet GE, et autres
Publié: (2013) -
Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
par: Fabrizio Facchinetti, et autres
Publié: (2021) -
Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
par: Priyadarshini Kachroo, et autres
Publié: (2021)